Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Rosetta Genomics Ltd.
  6. Summary
    ROSGQ   IL0011026494

ROSETTA GENOMICS LTD.

(ROSGQ)
 SummaryQuotesChartsNewsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Markets
10/04/2021 10/05/2021 10/07/2021 10/11/2021 10/13/2021 Date
0(c) 0.0002(c) 0(c) 0.0002(c) 0.0003(c) Last
67 2 400 32 14 127 584 Volume
-100.00% -100.00% +50.00% Change
More quotes
Company
Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests-based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH). The Company is... 
More about the company
All news about ROSETTA GENOMICS LTD.
2018Genoptix, Inc. cancelled the acquisition of Rosetta Genomics Ltd..
CI
2018ROSETTA GENOMICS LTD.(NASDAQCM : ROSG) dropped from NASDAQ Composite Index
CI
2018Rosetta Genomics Ltd. Announces Resignation of Ken Berlin as President and CEO, Effecti..
CI
2018Genoptix, Inc. and Rosetta Genomics Ltd. Enter into Agreement to Market and Distribute ..
CI
2018Genoptix, Inc. completed the acquisition of PDx Business of Rosetta Genomics Ltd..
CI
2018Genoptix, Inc. entered into a definitive agreement to acquire PDx Business of Rosetta G..
CI
2018Genoptix, Inc. entered into a merger agreement to acquire Rosetta Genomics Ltd. for $8 ..
CI
2018Genoptix, Inc. cancelled the proposed acquisition of Rosetta Genomics Ltd..
CI
2017Genoptix, Inc. entered into a term sheet agreement to acquire Rosetta Genomics Ltd..
CI
2017Rosetta Genomics Ltd. Announces Resignation of David Sidransky as Director
CI
2017Certain Restricted Stock Units of Rosetta Genomics Ltd. are subject to a Lock-Up Agreem..
CI
2017Certain Warrants of Rosetta Genomics Ltd. are subject to a Lock-Up Agreement Ending on ..
CI
2017Certain Stock Options of Rosetta Genomics Ltd. are subject to a Lock-Up Agreement Endin..
CI
2017Certain Ordinary Shares of Rosetta Genomics Ltd. are subject to a Lock-Up Agreement End..
CI
2017Pragmin Prognosis cancelled the acquisition of CYNOGEN Inc. from Rosetta Genomics Ltd..
CI
More news
News in other languages on ROSETTA GENOMICS LTD.

- No features available -

More news
Chart ROSETTA GENOMICS LTD.
Duration : Period :
Rosetta Genomics Ltd. Technical Analysis Chart | ROSGQ | IL0011026494 | MarketScreener
Managers and Directors
Ron Kalfus Chief Financial Officer
David Sidransky Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ROSETTA GENOMICS LTD.-98.50%0
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
IQVIA HOLDINGS INC.38.89%47 683
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414